These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2196537)

  • 1. Aminoglycosides: another look at current and future roles in antimicrobial therapy.
    Murphy JE
    Pharmacotherapy; 1990; 10(3):217-23. PubMed ID: 2196537
    [No Abstract]   [Full Text] [Related]  

  • 2. More on variability in aminoglycoside volume of distribution.
    Dasta JF; Armstrong DK
    Clin Pharm; 1987 Mar; 6(3):193. PubMed ID: 3665376
    [No Abstract]   [Full Text] [Related]  

  • 3. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology.
    Miller MM; Burton ME; Johnson PN; Miller JL
    Am J Health Syst Pharm; 2014 Dec; 71(24):2108-9. PubMed ID: 25465576
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber.
    Perry AC; Rouse MS; Khaliq Y; Piper KE; Hanssen AD; Osmon DR; Steckelberg JM; Patel R
    Clin Orthop Relat Res; 2002 Oct; (403):49-53. PubMed ID: 12360007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin].
    Juvin ME; Drugeon HB; Caillon J; Pirault JL
    Pathol Biol (Paris); 1987 May; 35(5):461-5. PubMed ID: 3302848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.
    Mathews A; Bailie GR
    J Clin Pharm Ther; 1987 Oct; 12(5):273-91. PubMed ID: 3119606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
    Bookstaver PB; Johnson JW; McCoy TP; Stewart D; Williamson JC
    Ann Pharmacother; 2008 Dec; 42(12):1758-65. PubMed ID: 19047358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily versus pharmacokinetic dosing of aminoglycosides.
    Medicus-Bringa M; Ward G; Rice M
    Am J Med; 1997 Oct; 103(4):328-30. PubMed ID: 9382126
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
    Hostacká A
    J Basic Microbiol; 1998; 38(5-6):383-8. PubMed ID: 9871334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
    Ling GV; Conzelman GM; Franti CE; Ruby AL
    Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in aminoglycoside volume of distribution in patients below ideal body weight.
    Tointon MM; Job ML; Peltier TT; Murphy JE; Ward ES
    Clin Pharm; 1987 Feb; 6(2):160-2. PubMed ID: 3665369
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested].
    Alegente G; Marchi B; Pieri I; Saturni A; Progenie G; Rubino M
    Quad Sclavo Diagn; 1983 Sep; 19(3):343-8. PubMed ID: 6677931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A closer look at aminoglycosides.
    DeTorres OH
    Clin Ther; 1981; 3(6):399-412. PubMed ID: 7260986
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotic stability in an implantable pump.
    Perry CR; Ellington LL; Becker A; Vossen MK; Burdge RE; Greenberg RN
    J Orthop Res; 1986; 4(4):494-8. PubMed ID: 3783303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of resistance to netilmicin and other aminoglycosides.
    Toscano MA; Russo G; Nicoletti G; Stefani S; Geraci C; Alessandria E
    Chemioterapia; 1986 Jun; 5(3):191-5. PubMed ID: 3719853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man.
    De Broe ME; Verbist L; Verpooten GA
    J Antimicrob Chemother; 1991 May; 27 Suppl C():41-7. PubMed ID: 1856145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal aminoglycoside dosing in critically ill patients.
    Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
    Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.